e-learning
resources
ERJ
2009
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease
Khaldi H., Marchand-Adam S., Kannengiesser C., Fabre A., Debray M. P., Danel C., Gougerot-Pocidalo M-A., El Benna J., Humbert M., Aubier M., Crestani B.
Source:
Eur Respir J 2009; 33: 1498-1502
Journal Issue:
June
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Khaldi H., Marchand-Adam S., Kannengiesser C., Fabre A., Debray M. P., Danel C., Gougerot-Pocidalo M-A., El Benna J., Humbert M., Aubier M., Crestani B.. Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease. Eur Respir J 2009; 33: 1498-1502
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Pulmonary hypertension in interstitial lung disease
Source: Eur Respir J 2008; 31: 1357-1367
Year: 2008
Emergencies in interstitial and immunological lung disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=177
Year: 2006
Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 40: 93-100
Year: 2012
Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
Source: Eur Respir J 2005; 26: 586-593
Year: 2005
Pulmonary hypertension associated with obliterative phlebitis in IgG4-related lung disease
Source: Eur Respir J 2015; 45: 842-845
Year: 2015
Granulomatous angiitis leading to a pulmonary veno-occlusive disease-like picture
Source: Eur Respir J 2009; 33: 666-669
Year: 2009
Non-pulmonary comorbidities in idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease
Source: Eur Respir Rev 2009; 18: 129-132
Year: 2009
Clinical features of usual interstitial pneumonia-correlation between idiopathic pulmonary fibrosis and connective tissue disease associated with usual interstitial pneumonia
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Prognostic significance of selected biomarkers in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease
Source: International Congress 2014 – Sarcoidosis
Year: 2014
Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia
Source: International Congress 2015 – Treatment of IPF
Year: 2015
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
Source: Eur Respir J 2010; 35: 105-111
Year: 2010
Comparison between patients with idiopathic pulmonary fibrosis and patients with pulmonary involvement of the usual interstitial pneumonia pattern that preceded the onset of rheumatoid arthritis
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Using the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Pulmonary hypertension complicating fibrosing mediastinitis
Source: International Congress 2016 – Clinic of pulmonary hypertension
Year: 2016
Idiopathic pulmonary haemosiderosis revisited
Source: Eur Respir J 2004; 24: 162-169
Year: 2004
Pulmonary hypertension is common in end-stage sarcoidosis
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005
Disease of the airways in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: 41S-49S
Year: 2001
Systemic effects of chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 347-360
Year: 2003
Systemic inflammation in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 5S-13S
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept